Triple
T33388730
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Seagen |
E854988
|
entity |
| Predicate | tisotumabVedotinIndication |
P113308
|
FINISHED |
| Object | recurrent or metastatic cervical cancer |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: recurrent or metastatic cervical cancer | Statement: [Seagen, tisotumabVedotinIndication, recurrent or metastatic cervical cancer]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: tisotumabVedotinIndication Context triple: [Seagen, tisotumabVedotinIndication, recurrent or metastatic cervical cancer]
-
A.
isTumorAgnostic
Indicates that a treatment, biomarker, or effect applies across multiple tumor types regardless of the cancer’s tissue or organ of origin.
-
B.
treatmentIndication
chosen
Indicates that a treatment is intended to address, alleviate, or prevent a particular condition, symptom, or medical indication.
-
C.
isIndicatedAsMonotherapyFor
Indicates that a treatment is recommended or used alone, without combination with other therapies, for a particular condition or purpose.
-
D.
hasDoseLimitingToxicity
Indicates that a treatment or substance produces a level of toxicity severe enough to prevent further dose escalation or limit the maximum tolerated dose.
-
E.
indicationTestedIn
Indicates that a particular medical indication (disease or condition) has been evaluated or tested in a specified clinical study or experimental context.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69f3496d54048190a1cb91fdd7caa6ea |
completed | April 30, 2026, 12:22 p.m. |
| NER | Named-entity recognition | batch_69f6f38159d08190980ad639e08f00f4 |
completed | May 3, 2026, 7:04 a.m. |
| PD | Predicate disambiguation | batch_69f6e3d7bee48190b94e0beb48a1d7fa |
completed | May 3, 2026, 5:57 a.m. |
Created at: May 1, 2026, 1:35 a.m.